Aldevron adds AAV plasmid product offerings

By The Science Advisory Board staff writers

January 12, 2021 -- Aldevron has launched rep/cap plasmids to support adeno-associated virus (AAV) vector manufacturing.

Rep/cap plasmids are essential components of the AAV genome and are required for the production of recombinant AAV.

The research grade product, pALD-AAV6 is immediately available at the good manufacturing practice (GMP) source quality level, while pALD-AAV2 and pALD-AAV5 will be made available based on market demand. These products are designed to support preclinical activities through clinical development and commercial production, according to Aldevron.

"Along with offering catalog items, we have increased capacity and reduced lead times, providing us the ability to scale while meeting important client deadlines," Michelle Berg, president of Aldevron's GMP nucleic acids business unit.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.